Aker BioMarine wins new business for Superba Krill Oil

Aker BioMarine has secured a new Superba Krill Oil business. On a full-year run-rate basis, this business would rank among the company's largest customer relationships. Deliveries on the first purchase order commence in Q4 2026.

“I am very pleased to secure another significant win for Superba Krill Oil. Wins of this scale, alongside continued momentum across our broader customer base, are what drive sustainable long-term growth,” said Matts Johansen, CEO of Aker BioMarine.

For further information, please contact Christopher Robin Vinter, SVP Finance Mobile: +47 911 60 820 Email: Christopher.vinter@akerbiomarine.com

This information is considered to be inside information pursuant to the EU Market Abuse Regulation article 7 and is subject to the disclosure requirements pursuant to MAR article 17 and Section 5-12 the Norwegian Securities Trading Act. This stock exchange announcement was published by Christopher Vinter, SVP Finance, Aker BioMarine ASA, on July 10, 2026, 06:55 CET.

About Aker BioMarine Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.